Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases? - PubMed (original) (raw)

Review

Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

Daniele Pastori et al. Intern Emerg Med. 2014 Mar.

Abstract

Growing evidences suggest that reactive oxidant species (ROS) are involved in the pathogenesis and progression of the atherosclerotic diseases. Markers assessing the oxidation of LDL and formation of eicosanoids, such as isoprostanes, were among the first that were analyzed. More recently, new biomarkers, such as endogenous secretory receptor for AGEs have been suggested to play an oxidative role in specific atherosclerotic settings, such as diabetes. Unfortunately, clinical trials included cross-sectional as well as retrospective and prospective studies which provide inconclusive results. Thus, clear evidence that oxidative biomarkers can improve risk stratification in addition to the common used atherosclerotic risk factors is still lacking. The analysis of oxidative stress focused on enzymatic systems generating ROS. The most studied enzymes were NADPH oxidase and myeloperoxidase (MPO). Experimental and clinical studies suggest that both enzymes may be implicated in promoting atherosclerotic disease. Novel laboratory methodologies have been, therefore, developed to study NADPH oxidase and MPO in patients with stable atherosclerosis as well in patients with acute coronary syndrome and cerebrovascular accident. This review will report on the more relevant studies in which the clinical application of the oxidative biomarkers was evaluated.

PubMed Disclaimer

Similar articles

• Clinical Application of NOX Activity and Other Oxidative Biomarkers in Cardiovascular Disease: A Critical Review.
  Violi F, Pignatelli P. Violi F, et al. Antioxid Redox Signal. 2015 Aug 10;23(5):514-32. doi: 10.1089/ars.2013.5790. Epub 2014 Feb 24. Antioxid Redox Signal. 2015. PMID: 24382131 Review.
• Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells.
  Aguilar EC, Santos LC, Leonel AJ, de Oliveira JS, Santos EA, Navia-Pelaez JM, da Silva JF, Mendes BP, Capettini LS, Teixeira LG, Lemos VS, Alvarez-Leite JI. Aguilar EC, et al. J Nutr Biochem. 2016 Aug;34:99-105. doi: 10.1016/j.jnutbio.2016.05.002. Epub 2016 May 16. J Nutr Biochem. 2016. PMID: 27261536
• The role of oxidative stress and NADPH oxidase in the pathogenesis of atherosclerosis.
  Bryk D, Olejarz W, Zapolska-Downar D. Bryk D, et al. Postepy Hig Med Dosw (Online). 2017 Jan 28;71(0):57-68. doi: 10.5604/17322693.1229823. Postepy Hig Med Dosw (Online). 2017. PMID: 28181912 Review.
• Oxidative stress and cardiovascular disease: new insights.
  Pignatelli P, Menichelli D, Pastori D, Violi F. Pignatelli P, et al. Kardiol Pol. 2018;76(4):713-722. doi: 10.5603/KP.a2018.0071. Epub 2018 Mar 14. Kardiol Pol. 2018. PMID: 29537483 Review.

Cited by

• Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers.
  Signorelli SS, Scuto S, Marino E, Xourafa A, Gaudio A. Signorelli SS, et al. Antioxidants (Basel). 2019 Sep 2;8(9):367. doi: 10.3390/antiox8090367. Antioxidants (Basel). 2019. PMID: 31480714 Free PMC article. Review.
• 8-Isoprostanes and Asymmetric Dimethylarginine as Predictors of Mortality in Patients Following Coronary Bypass Surgery: A Long-Term Follow-Up Study.
  Gołąb A, Plicner D, Rzucidło-Hymczak A, Tomkiewicz-Pająk L, Gawęda B, Kapelak B, Undas A. Gołąb A, et al. J Clin Med. 2022 Jan 4;11(1):246. doi: 10.3390/jcm11010246. J Clin Med. 2022. PMID: 35011987 Free PMC article.
• Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects.
  Violi F, Loffredo L, Pignatelli P, Angelico F, Bartimoccia S, Nocella C, Cangemi R, Petruccioli A, Monticolo R, Pastori D, Carnevale R. Violi F, et al. Nutr Diabetes. 2015 Jul 20;5(7):e172. doi: 10.1038/nutd.2015.23. Nutr Diabetes. 2015. PMID: 26192450 Free PMC article.
• Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
  Biccirè FG, Bucci T, Menichelli D, Cammisotto V, Pignatelli P, Carnevale R, Pastori D. Biccirè FG, et al. Nutrients. 2022 Mar 16;14(6):1260. doi: 10.3390/nu14061260. Nutrients. 2022. PMID: 35334916 Free PMC article. Review.
• Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study.
  Menichelli D, Carnevale R, Nocella C, Cammisotto V, Castellani V, Bartimoccia S, Frati G, Pignatelli P, Pastori D. Menichelli D, et al. Front Cardiovasc Med. 2021 Nov 17;8:779503. doi: 10.3389/fcvm.2021.779503. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34869693 Free PMC article.

References

1. 1. J Clin Invest. 1997 May 1;99(9):2075-81 - PubMed
2. 1. Clin Chem. 2012 Jan;58(1):246-56 - PubMed
3. 1. J Am Coll Cardiol. 2006 Jun 6;47(11):2212-8 - PubMed
4. 1. Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):877-83 - PubMed
5. 1. Circulation. 2004 Aug 31;110(9):1134-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal